1. Home
  2. NXL vs IPW Comparison

NXL vs IPW Comparison

Compare NXL & IPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • IPW
  • Stock Information
  • Founded
  • NXL 2010
  • IPW 2018
  • Country
  • NXL United States
  • IPW United States
  • Employees
  • NXL N/A
  • IPW N/A
  • Industry
  • NXL Medical Specialities
  • IPW Catalog/Specialty Distribution
  • Sector
  • NXL Health Care
  • IPW Consumer Discretionary
  • Exchange
  • NXL Nasdaq
  • IPW Nasdaq
  • Market Cap
  • NXL 21.0M
  • IPW 19.8M
  • IPO Year
  • NXL 2022
  • IPW 2021
  • Fundamental
  • Price
  • NXL $0.89
  • IPW $0.58
  • Analyst Decision
  • NXL Strong Buy
  • IPW
  • Analyst Count
  • NXL 1
  • IPW 0
  • Target Price
  • NXL $5.00
  • IPW N/A
  • AVG Volume (30 Days)
  • NXL 123.3K
  • IPW 105.1K
  • Earning Date
  • NXL 08-06-2025
  • IPW 09-18-2025
  • Dividend Yield
  • NXL N/A
  • IPW N/A
  • EPS Growth
  • NXL N/A
  • IPW N/A
  • EPS
  • NXL N/A
  • IPW N/A
  • Revenue
  • NXL $174,813.00
  • IPW $74,105,251.00
  • Revenue This Year
  • NXL $79.59
  • IPW $8.31
  • Revenue Next Year
  • NXL $334.65
  • IPW $77.15
  • P/E Ratio
  • NXL N/A
  • IPW N/A
  • Revenue Growth
  • NXL 16.42
  • IPW N/A
  • 52 Week Low
  • NXL $0.59
  • IPW $0.41
  • 52 Week High
  • NXL $4.49
  • IPW $2.36
  • Technical
  • Relative Strength Index (RSI)
  • NXL 33.31
  • IPW 38.77
  • Support Level
  • NXL $0.86
  • IPW $0.58
  • Resistance Level
  • NXL $1.10
  • IPW $0.70
  • Average True Range (ATR)
  • NXL 0.09
  • IPW 0.04
  • MACD
  • NXL -0.02
  • IPW -0.01
  • Stochastic Oscillator
  • NXL 7.30
  • IPW 0.81

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About IPW iPower Inc.

iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.

Share on Social Networks: